Fig. 2

Cumulative incidence of irAEs in patients with “high” vs “low” autoAb at baseline using different cut-offs. A Cumulative incidence of irAEs in patients with “high” vs “low” levels of elevated IgG and IgM at baseline using MFI 500 and 950 as cut-offs. B Cumulative incidence of irAEs in patients with “high” vs “low” levels of elevated IgG at baseline using MFI 500 and 200 as cut-offs. C Cumulative incidence of irAEs in patients with “high” vs “low” levels of elevated IgM at baseline using MFI 500 and 1500 as cut-offs